Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive …
Objectives This study assessed the effectiveness of the oral antiviral agents nirmatrelvir–
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
Objectives This study investigated the association between nirmatrelvir plus ritonavir (NMV-
r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 …
r) or molnupiravir and the outcomes of non-hospitalized high-risk patients with COVID-19 …
[HTML][HTML] Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients
Background The outcomes of older adult people acquiring SARS-CoV-2 reinfection was
unclear. This study aimed to compare the outcomes of older adult patients with COVID-19 …
unclear. This study aimed to compare the outcomes of older adult patients with COVID-19 …
[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐and long‐term outcome in high‐risk children with COVID‐19
This study investigated the clinical effectiveness of nirmatrelvir plus ritonavir (NMV‐r) on
short‐term outcome and the risk of postacute sequelae of severe acute respiratory syndrome …
short‐term outcome and the risk of postacute sequelae of severe acute respiratory syndrome …
[HTML][HTML] Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders
TH Liu, HY Liao, CC Chang, CC Lai - Frontiers in Pharmacology, 2024 - frontiersin.org
Objectives This study investigated the clinical effectiveness of molnupiravir for treating non-
hospitalized COVID-19 patients with pre-existing psychiatric disorder. Methods This …
hospitalized COVID-19 patients with pre-existing psychiatric disorder. Methods This …
[HTML][HTML] Malnutrition and the Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Multi-Institutional Population-Based Propensity …
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has led to a global health crisis, exacerbating issues like …
coronavirus 2 (SARS-CoV-2), has led to a global health crisis, exacerbating issues like …
Comment on" Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19"
YL Lin, CH Yu, JCC Wei - International journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Comment on "Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized
obese patients with COVID-19" Comment on "Association between nirmatrelvir plus ritonavir …
obese patients with COVID-19" Comment on "Association between nirmatrelvir plus ritonavir …